Lasers have been identified as one of the preventive tools that can be utilised to prevent white spot lesion in ortho- dontic practice. The aim of this scoping review was to evaluate the current scientific literature on the use of lasers specifically to prevent white spot lesion in orthodontic cases. Search was performed in PubMed, Web of Science, Scopus and EBSCO databases from the past ten years. The records obtained were peruse considering specific in- clusion and exclusion criteria. From the total of 1123 studies that were evaluated, 68 papers were included for this review. A variety of laser types has been reported including Er;YAG, Er,Cr:YSGG, Argon and CO2 lasers. CO2 laser has a good number of evidence of it’s positive result and can be suggested to be use in clinical practise. However, since most data for the other type of lasers were derived from in vitro studies, they must be interpreted with care. Randomised clinical trials would be beneficial to give more meaningful evidence for clinicians to adopt lasers in their practice.
This study aimed to review the availability of sugar-free medicine available in the market using the online Monthly Index of Medical Specialties (MIMS) Malaysia 2016. Data collection was obtained from product information (PI) for prescription medications contained in the MIMS Malaysia 2016. Concise information for each product was collected based on therapeutic class groupings. The therapeutic class obtained from PI was assigned to one of the 11 major therapeutic classes. PI that stated its use in paediatrics was further reviewed for the availability of sugar free ingredient. Each product was then allocated into the poison groups: Group B, Group C and Non-Scheduled Poison. A total of 282 PI items from 336 companies in MIMS Malaysia 2016 that satisfied our eligibility criteria were reviewed. Of the 282 PI items reviewed, most of the products, 169 (59.9%) were sugarbased product, while 87 (30.9%) of them belong to sugar free products. Our study found that most of the medicines reviewed in the MIMS Malaysia 2016 were under Group C (134 of total 282). There is still a high number of sugar-containing medicines despite the promotion of sugar-free medication. Therefore, consumers need to be educated on the use of sugar-free medicines in children to increase the demand and availability in the market.
Introduction: Coated archwires improve aesthetics during orthodontic treatment. However, little is known regarding
their clinical benefit. This randomised controlled trial (RCT) compared the tooth alignment (TA), coating loss (CL),
colour change (∆E*), and patient perception of coated archwires with their controls. Details of ∆E* and perception were reported in the second part of the articles. Methods: This RCT was done at three centres. Participants
were randomised to receive one of four treatment interventions using 0.014” superelastic coated nickel-titanium
archwires from Orthocare, RMO, G&H, and conventional uncoated 3M Unitek® archwires. These archwires were
ligated during bonding and collected after eighth week and questionnaires were distributed to participants in the
experimental groups only. After removal, TA and CL were measured using Little’s Irregularity Index and Autodesk®
AutoCAD® software, respectively. At the time of this preliminary reporting, 84 participants had completed the trial. Two archwires fractured and were excluded. Therefore, 166 archwires (n = 166) were analysed. Results: Only
non-extraction cases showed statistically significant differences in TA change between all groups (p = 0.005) and
RMO showed significantly lowest mean of TA (1.5 mm). RMO and Orthocare showed significant TA change in the
upper and lower arches (p = 0.037, 0.048). CL was found to be insignificant for both extraction and non-extraction
cases (p >0.05). Comparison between upper and lower arches revealed no significant difference in TA and CL in all
groups (p >0.05). Conclusion: From this preliminary analysis, Orthocare provides better TA in non-extraction cases
despite highest percentage of coating loss.
Introduction: Coated archwires improve aesthetics because of the tooth-coloured appearance. However, colour change of the coated archwires have been reported in vitro. Nonetheless, little is known to what extent this colour change occurs clinically. This second part of the multi-centre, double-blind, randomised controlled trial evaluated the colour change (E*) of three coated archwires with their controls and patient perception. Methods: 84 patients who received treatment with upper and lower fixed appliance treatment were invited. Consented patients were randomised to receive one of four treatment interventions using 0.014” superelastic nickel-titanium archwires from
(1) Orthocare (2) RMO (3) G&H, and (4) 3M Unitek® uncoated. These archwires were ligated during bonding and collected after 8th week. After removal, the digital images of the archwires were assessed for colour change using Adobe® Photoshop® software, and the CIE L*a*b* system was used to calculate the ΔE* values. Patient perception was measured using oral aesthetic subjective impact scale (OASIS) questionnaire. Results: For colour change and patient perception assessment, 132 archwires from 66 participants who had been treated with aesthetic archwires were collected. Two fractured archwires were excluded. Initial analysis revealed all three aesthetic archwires groups showed significant mean of E* with the highest was found in Orthocare (23.9), and the lowest is G&H (16.8). Post hoc comparison revealed statistically significant mean of E* in Orthocare when compared with other groups (p